实用肿瘤学杂志 ›› 2020, Vol. 34 ›› Issue (2): 185-188.doi: 10.11904/j.issn.1002-3070.2020.02.018

• 综 述 • 上一篇    下一篇

SPDEF与恶性肿瘤关系的研究进展

林玉华, 倪振华, 孙亦鹏, 毕俊杰 综述, 王雄彪 审校   

  1. 上海中医药大学附属普陀医院(上海 200333)
  • 收稿日期:2019-10-23 发布日期:2020-04-27
  • 通讯作者: 王雄彪,E-mail:xiongbiao6@hotmail.com
  • 作者简介:林玉华,女,(1993-),硕士研究生,从事肺癌发病机制的研究。
  • 基金资助:
    上海市科学技术委员会科研计划项目(编号:18140904000;17401970900);上海市普陀区自主创新科研项目/基本项目(编号:ptkwws201714)

Research progress on the relationship between SPDEF and malignant tumors

LIN Yuhua, NI Zhenhua, SUN Yipeng, BI Junjie, WANG Xiongbiao   

  1. Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200333,China
  • Received:2019-10-23 Published:2020-04-27

摘要: 含SAM尖端结构域的E26转化特异性因子(SAM pointed domain cintaining Ets transcription factor,SPDEF)是Ets转录因子家族的成员之一。SPDEF又称为前列腺源性Ets因子(Prostate-derived Ets factor,PDEF),最初在前列腺癌中发现,在前列腺癌进展过程中发挥重要作用,作为前列腺特异性抗原基因(PSA)启动子的非雄激素依赖性转录激活因子。目前研究发现SPDEF在前列腺癌、乳腺癌和肺癌等不同组织中发挥抑制肿瘤或促进肿瘤的作用,但其具体机制仍未完全阐明。本文主要介绍SPDEF的结构和SPDEF在不同肿瘤中的调控机制,预期SPDEF在肿瘤中的重要作用,为相关肿瘤的防治提供了新思路。

关键词: SPDEF, 恶性肿瘤, 调控机制

Abstract: SAM pointed domain cintaining Ets transcription factor(SPDEF)is a member of the Ets transcription factor family.SPDEF is also known as prostate-derived Ets factor(PDEF).It was originally found in prostate cancer and plays an important role in the progression of prostate cancer,acting as a prostate-specific antigen(PSA)promoter for a non-androgen-dependent transcriptional activator.Current many studies have found that SPDEF plays a role in inhibiting tumors or promoting tumors in different tissues such as prostate cancer,breast cancer and lung cancer,but the specific mechanism has not been fully elucidated.This article mainly introduces the structure of SPDEF and the regulatory mechanism of SPDEF in different tumors.The important role of SPDEF in tumors is expected to provide new ideas for the prevention and treatment of related tumors.

Key words: SPDEF, Malignant tumor, Regulatory mechanism

中图分类号: